Skin Neoplasms

"Skin Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the SKIN.

Descriptor ID	D012878
MeSH Number(s)	C04.588.805 C17.800.882
Concept/Terms	Skin Neoplasms Skin Neoplasms Neoplasms, Skin Neoplasm, Skin Skin Neoplasm Cancer of Skin Cancer of Skin Skin Cancers Cancer of the Skin Skin Cancer Cancer, Skin Cancers, Skin

Below are MeSH descriptors whose meaning is more general than "Skin Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Skin Neoplasms [C04.588.805]
Skin and Connective Tissue Diseases [C17]
Skin Diseases [C17.800]
Skin Neoplasms [C17.800.882]

Below are MeSH descriptors whose meaning is related to "Skin Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Skin Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Skin Neoplasms" by people in this website by year, and whether "Skin Neoplasms" was a major or minor topic of these publications.

Bar chart showing 2060 publications over 30 distinct years, with a maximum of 116 publications in 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1991	17	2	19
1992	19	2	21
1993	14	9	23
1994	29	5	34
1995	32	5	37
1996	28	7	35
1997	39	4	43
1998	45	4	49
1999	34	5	39
2000	43	9	52
2001	52	3	55
2002	67	4	71
2003	70	12	82
2004	53	7	60
2005	64	13	77
2006	83	12	95
2007	74	7	81
2008	84	6	90
2009	69	8	77
2010	84	9	93
2011	107	9	116
2012	90	11	101
2013	86	10	96
2014	84	20	104
2015	85	10	95
2016	77	11	88
2017	104	7	111
2018	97	9	106
2019	71	6	77
2020	31	2	33

Below are the most recent publications written about "Skin Neoplasms" by people in Profiles.

Dummer R, Lebbé C, Atkinson V, Mandalà M, Nathan PD, Arance A, Richtig E, Yamazaki N, Robert C, Schadendorf D, Tawbi HA, Ascierto PA, Ribas A, Flaherty KT, Pakhle N, Campbell CD, Gusenleitner D, Masood A, Brase JC, Gasal E, Long GV. Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i. Nat Med. 2020 10; 26(10):1557-1563.

View in: PubMed
Dummer R, Hauschild A, Santinami M, Atkinson V, Mandalà M, Kirkwood JM, Chiarion Sileni V, Larkin J, Nyakas M, Dutriaux C, Haydon A, Robert C, Mortier L, Schachter J, Lesimple T, Plummer R, Dasgupta K, Gasal E, Tan M, Long GV, Schadendorf D. Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma. N Engl J Med. 2020 09 17; 383(12):1139-1148.

View in: PubMed
Mahajan P, Venkatramani R. Comment on: Solitary myofibroma preceding the development of multicentric myofibromatosis: A report of two cases with surveillance recommendations. Pediatr Blood Cancer. 2020 11; 67(11):e28637.

View in: PubMed
Tetzlaff MT, Adhikari C, Lo S, Rawson RV, Amaria RN, Menzies AM, Wilmott JS, Ferguson PM, Ross MI, Spillane AJ, Vu KA, Ma J, Ning J, Haydu LE, Saw RPM, Wargo JA, Tawbi HA, Gershenwald JE, Long GV, Davies MA, Scolyer RA. Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma. Ann Oncol. 2020 11; 31(11):1569-1579.

View in: PubMed
Gu N, Dai W, Liu H, Ge J, Luo S, Cho E, Amos CI, Lee JE, Li X, Nan H, Yuan H, Wei Q. Genetic variants in TKT and DERA in the nicotinamide adenine dinucleotide phosphate pathway predict melanoma survival. Eur J Cancer. 2020 09; 136:84-94.

View in: PubMed
Olshinka A, Maricevich R, Shay T, Cohen AA, Ad-El D, Ali K. Algorithm for Temple Reconstruction With Consideration of Anatomic and Defect Characteristics. J Craniofac Surg. 2020 Jul-Aug; 31(5):1261-1265.

View in: PubMed
Dummer R, Prince HM, Whittaker S, Horwitz SM, Kim YH, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Eradat H, Pinter-Brown L, Sanches JA, Ortiz-Romero PL, Akilov OE, Geskin L, Huen A, Walewski J, Wang Y, Lisano J, Richhariya A, Feliciano J, Zhu Y, Bunn V, Little M, Zagadailov E, Dalal MR, Duvic M. Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study. Eur J Cancer. 2020 07; 133:120-130.

View in: PubMed
Petersen ET, Ahmed SR, Pradhan D, MacFarlane DF. Superficial Basal Cell Cancers Demonstrate Higher Rates of Mixed Histology on High-Risk Anatomical Sites. Dermatol Surg. 2020 06; 46(6):747-751.

View in: PubMed
Frieden IJ, Püttgen KB, Drolet BA, Garzon MC, Chamlin SL, Pope E, Mancini AJ, Lauren CT, Mathes EF, Siegel DH, Gupta D, Haggstrom AN, Tollefson MM, Baselga E, Morel KD, Shah SD, Holland KE, Adams DM, Horii KA, Newell BD, Powell J, McCuaig CC, Nopper AJ, Metry DW, Maguiness S. Management of infantile hemangiomas during the COVID pandemic. Pediatr Dermatol. 2020 May; 37(3):412-418.

View in: PubMed
Thrift AP, Gudenkauf FJ. Melanoma Incidence Among Non-Hispanic Whites in All 50 US States From 2001 Through 2015. J Natl Cancer Inst. 2020 05 01; 112(5):533-539.

View in: PubMed

People

Explore

Similar Concepts

Top Journals